SAREPTA THERAPEUTICS INC earnings per share and revenue

AB3A earnings per share for the last quarter are 0.34 EUR whereas the estimation was 0.01 EUR which accounts for 2765.11% surprise. Company revenue for the same period amounts to 383.19 M EUR despite the estimated figure of 351.73 M EUR. Estimated earnings per share for the next quarter are -0.12 EUR, and revenue is expected to reach 368.07 M EUR. Also watch annual changes over time to get a bigger picture of AB3A earnings per share and revenue dynamics.